Blog - Page 1515 of 5718

WednesdayFeb 10, 2021 3:28 pm

evTS Reveals Urban Delivery Focus for 2021, Additions to Board of Directors

ev Transportation Services (“evTS”) helps operators of essential services fleets with versatile vehicle solutions FireFly has a lower cost of ownership because of minimal operation and maintenance (O&M) costs FireFly ESV is a task flexible urban mobility solution that “goes fast, goes further and carries heavier loads” Additions to Board of Directors offer invaluable experience to help evTS prosper, grow into positive cash flow by end of 2021 ev Transportation Services (“evTS”) is a privately owned specialty vehicle manufacturer that produces purpose-built, all-electric, lightweight commercial utility vehicles and provides fleet management solutions primarily for the essential services transportation and urban…

WednesdayFeb 10, 2021 3:14 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc. Provides Antigen Rapid POC Test as part of Comprehensive COVID-19 Strategy

United Medical Equipment (“UME,” “UMEBSNI”) is committed to offering high-quality COVID-19 services, solutions and supplies. Among these, UME provides the CareStart(TM) COVID-19 Antigen Rapid POC test. The test can be administered by authorized laboratories and at the point of care by medical professionals to detect the presence of the SARS-CoV-2 nucleocapsid protein antigen. The innovative test features a 10-minute processing time and provides the capability to identify acute infection with 88.4% sensitivity and 100% specificity. A recent article discussing this reads, “The CareStart product is part of a UME’s comprehensive COVID-19 monitoring strategy, which was carefully designed with the assistance…

WednesdayFeb 10, 2021 3:03 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, expects to achieve important milestones in the year ahead. The company’s proprietary i/Blue Imaging System is designed to significantly enhance surgeons’ ability to visualize and remove cancer cells using blue light by combining advanced optics and light sensors with a contrast imaging agent. The system’s key feature is its adaptability to almost any scope already in use by hospitals and surgical centers. Despite the challenges of 2020, Imagin was able to transition its product from the development stage to manufacturing, contracting with FDA registered and ISO 13485:2016-certified manufacturer Lighthouse Imaging.…

WednesdayFeb 10, 2021 2:53 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Poised as Insurtech Disrupts the Insurance Industry

InsuraGuest Technologies (TSXV: ISGI) (OTCQB: ISGIF) is positioned as technology has become a key factor and is generating significant changes in the insurance industry. The combination of insurance and technology (insurtech) is disrupting the insurance industry in its entirety, delivering better processes, efficiencies and customer experiences and new cost-saving solutions. A leader in the insurtech sector, InsuraGuest continues to expand its already impressive reach into multiple insurance markets. A recent article discussing this reads, “The company’s first target is the hospitality sector with intent to dominate what looks to be an incredibly lucrative segment. InsuraGuest Technologies’ latest landmark is the…

WednesdayFeb 10, 2021 2:42 pm

Mohawk Group Holdings Inc. (NASDAQ: MWK) Is ‘One to Watch’

The Mohawk Group Holdings Inc. management team offers deep industry experience with backgrounds in high profile industry names and title roles Mohawk’s proprietary AIMEE(R) drives new product development and automates sales and marketing while managing product lifecycle Mohawk’s business model leverages AIMEE(R) to offer a faster go-to-market strategy (6 to 8 months) than more traditional business models, which could take up to two years before marketing begins Mohawk’s strong annual revenue growth shows profitability while serving the massive and rapidly expanding e-commerce and direct-to-consumer (“D2C”) markets Mohawk is where CPG, e-commerce and technology intersect in the industry, proving a more…

WednesdayFeb 10, 2021 2:26 pm

HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Begins 2021 Strong with OTC Market Listing, New Product, and USDA Organic Certification

HempFusion Wellness Inc. is currently in the process of applying for OTCQX listing and DTC eligibility after a swift and strategic move to enter the OTC Pink Market under the ticker symbol ‘CBDHF’ Wholly owned subsidiary Probulin Probiotics recently released Total Care Immune probiotic, which is expected to reach retailer shelves in February 2021 Probulin is recognized as one of the fastest-growing probiotic brands in the American Natural Products Industry January, HempFusion received USDA Organic Certification for its CBD tinctures In a strategic move to broaden the United States investor audience, health and wellness company HempFusion Wellness (TSX: CBD.U) (OTC:…

WednesdayFeb 10, 2021 2:13 pm

Predictive Oncology Inc. (NASDAQ: POAI) Enters into Definitive Agreements for Direct Offering Totaling Estimated $3 Million

Definitive agreements with institutional, accredited investors call for issuance and sale of more than 3.5 million shares of common stock POAI currently focused on applying AI to develop personalized medical treatments, novel lab media and improved vaccines One of POAI’s highest priorities is building multi-omic predictive models of tumor drug response and outcome Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has entered into definitive agreements with several investors for the sale of common stock (https://ibn.fm/YcBGM). The agreements with several institutional and accredited investors call for the issuance and sale…

WednesdayFeb 10, 2021 1:58 pm

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Secures $24.2M in Initial Public Offering

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, has closed its initial public offering of 4,025,000 shares of its common stock, including an additional 525,000 shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Vivos Therapeutics secured approximately $24.2 million in gross proceeds, with each of the shares sold at the public offering price of $6.00. The common stock shares began trading on the Nasdaq Capital Market under the ticker symbol "VVOS" on Friday, Dec. 11, 2020. ROTH Capital Partners…

WednesdayFeb 10, 2021 1:51 pm

QualityStocksNewsBreaks – Knightscope Inc. Secures Order from Aerospace Client

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its receipt of a purchase order from a privately held American aerospace and national security contractor. According to the update, the company is excited to provide an innovative solution for the new client for an undisclosed mission at an undisclosed location. To view the full update, visit https://ibn.fm/S8Vtc About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots (“ASRs”) that deter, detect and report. The company’s long-term ambition is to make the United States of…

WednesdayFeb 10, 2021 1:36 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Achieves Record-Breaking Revenue for January 2021

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced record monthly gross revenue of $1,089,502 for January 2021. According to the update, January 2021’s revenue increased as compared to results for the month of December 2020 and during the highly dynamic holiday season, when the company achieved gross revenue of $1,029,883. January revenue exceeded management's expectations given that e-commerce sales were expected to be slower following the holiday season. This success during one of the slowest e-commerce periods of the year highlights the tremendous impact PlantX continues to have in the plant-based marketplace. "It is truly encouraging to…

Site Search

Company Search